Mesoblast (MESO) Interest Coverage Ratio (2014 - 2023)
Mesoblast (MESO) posted Interest Coverage Ratio of 3.93 for Q2 2023, down 1970.58% sequentially from 0.19 in Q1 2023, and down 86793.15% YoY from N/an in Q2 2022.
Mesoblast (MESO) Interest Coverage Ratio (2014 - 2023) Analysis & Trends
Mesoblast has reported Interest Coverage Ratio for 10 years, with the latest figure at 3.93 in Q2 2023.
- Quarterly Interest Coverage Ratio fell 86793.15% year-over-year to 3.93 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 1.85 (up 22.31% YoY) and the FY2025 annual result came in at 2.7, down 5.72% from the prior year.
- Interest Coverage Ratio eased to 3.93 in Q2 2023 per MESO's latest filing, from 0.19 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 7.99 in Q2 2019 and troughed at 7.64 in Q1 2019.
- A 5-year average of 2.23 and a median of 3.17 in 2020 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2023: Interest Coverage Ratio soared 207.82% in 2021, then tumbled 86793.15% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 6.46 in 2019, then grew by 16.13% to 5.41 in 2020, then surged by 207.82% to 5.84 in 2021, then sank by 122.24% to 1.3 in 2022, then sank by 202.89% to 3.93 in 2023.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 3.93, 0.19, and 1.3 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -3.93 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -1.30 |
| Sep 30, 2022 | -2.72 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | 5.84 |
| Sep 30, 2021 | -4.48 |
| Jun 30, 2021 | -4.44 |
| Mar 31, 2021 | -5.74 |
| Dec 31, 2020 | -5.41 |
| Sep 30, 2020 | -5.44 |
| Jun 30, 2020 | -0.90 |
| Mar 31, 2020 | -3.61 |
| Dec 31, 2019 | -6.46 |
| Sep 30, 2019 | -1.07 |
| Jun 30, 2019 | 7.99 |
| Mar 31, 2019 | -7.64 |
| Dec 31, 2018 | 12.05 |
| Sep 30, 2018 | 8.62 |